{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:49:38Z","timestamp":1761540578011,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":6615,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1111\/j.1538-7836.2004.00976.x","type":"journal-article","created":{"date-parts":[[2004,11,15]],"date-time":"2004-11-15T13:46:24Z","timestamp":1100526384000},"page":"2055-2056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Type 2B von Willebrand disease and related disorders of patients with increased ristocetin\u2010induced platelet aggregation: what they tell us about the role of von Willebrand factor in hemostasis"],"prefix":"10.1016","volume":"2","author":[{"given":"H.J.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0010","doi-asserted-by":"crossref","unstructured":"Ruggeri ZM. Type IIB von Willebrand disease: a paradox explains how von Willebrand factor works. J Thromb Haemost 2004; 2: 2\u20136.","DOI":"10.1111\/j.1538-7836.2003.00523.x"},{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0038-1653684","article-title":"Ristocetin \u2013 a new tool in the investigation of platelet aggregation","volume":"26","author":"Howard","year":"1971","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0020","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1172\/JCI107465","article-title":"Quantitative assay of a plasma factor, deficient in von in Willebrand's disease, that is necessary for platelet aggregation\u2013relationship to decreased factor VIII procoagulant activity and antigen content","volume":"52","author":"Weiss","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0025","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJM198202113060603","article-title":"Pseudo von Willebrand's disease: an intrinsic platelet defect with aggregation by unmodified human factor VIII\/von Willebrand factor and enhanced adsorption of its high molecular weight multimers","volume":"306","author":"Weiss","year":"1982","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0030","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0049-3848(80)90013-4","article-title":"Studies on the pathophysiology and treatment of von Willebrand's disease. IV. Mechanism of increased ristocetin\u2010induced platelet aggregation in von Willebrand's disease","volume":"19","author":"Takahashi","year":"1980","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0035","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V60.3.790.790","article-title":"Platelet\u2010type von Willebrand disease: characterization of a new bleeding disorder","volume":"60","author":"Miller","year":"1982","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0040","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1182\/blood.V64.6.1254.1254","article-title":"Further characterization of platelet\u2010type Willebrand's disease in Japan","volume":"64","author":"Takahashi","year":"1984","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0045","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1172\/JCI111112","article-title":"von Willebrand factor binds to platelets and induces aggregation in platelet\u2010type but not type IIB von Willebrand disease","volume":"72","author":"Miller","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0050","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1055\/s-0038-1650385","article-title":"Platelet\u2010type von Willebrand disease","volume":"75","author":"Miller","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V68.1.149.149","article-title":"A new von Willebrand variant (Type I, New York): increased ristocetin\u2010induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers","volume":"68","author":"Weiss","year":"1986","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0060","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood.V68.3.668.668","article-title":"von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma","volume":"68","author":"Holmberg","year":"1986","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0065","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1172\/JCI116443","article-title":"von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure","volume":"91","author":"Holmberg","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0070","doi-asserted-by":"crossref","unstructured":"Weiss HJ. The bleeding tendency in patients with low von Willebrand facto and.type 1 phenotype is greater in the presence of impaired collagen\u2010induced platelet aggregation. J Thromb Haemost 2004; 2: 2\u20136.","DOI":"10.1111\/j.1538-7836.2004.0562e.x"},{"key":"10.1111\/j.1538-7836.2004.00976.x_bb0075","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood.V80.4.988.988","article-title":"Shear rate\u2010dependent impairment of thrombus growth on collagen in nonanticoagulated blood from patients with von Willebrand Disease and Hemophilia A","volume":"80","author":"Fressinaud","year":"1992","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2004.00976.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622169473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622169473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2004.00976.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:30:03Z","timestamp":1761532203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622169473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S1538783622169473"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00976.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2B von Willebrand disease and related disorders of patients with increased ristocetin\u2010induced platelet aggregation: what they tell us about the role of von Willebrand factor in hemostasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00976.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}